Nesheim B I, Walloe L
Acta Obstet Gynecol Scand. 1976;55(4):315-6. doi: 10.3109/00016347609158504.
The "uterus-specific" beta-adrenoceptor stimulator isoxsuprine was used for the treatment of primary dysmenorrhea in a double-blind controlled clinical study. No significant beneficial effect of the drug was evident.
“子宫特异性”β-肾上腺素能受体刺激剂异舒普林在一项双盲对照临床研究中用于治疗原发性痛经。该药物未显示出明显的有益效果。